应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GRAL GRAIL, Inc.
交易中 10-02 12:20:51 EDT
13.38
+0.13
+0.98%
最高
13.71
最低
13.17
成交量
16.01万
今开
13.25
昨收
13.25
日振幅
4.08%
总市值
4.15亿
流通市值
4.15亿
总股本
3,105万
成交额
215.29万
换手率
0.52%
流通股本
3,105万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Grail, Inc.盘中异动 快速下挫5.21%
市场透视 · 10-01 02:23
Grail, Inc.盘中异动 快速下挫5.21%
Grail, Inc.盘中异动 快速拉升5.00%
市场透视 · 09-27
Grail, Inc.盘中异动 快速拉升5.00%
Grail, Inc.盘中异动 快速下挫5.14%报12.56美元
市场透视 · 09-26
Grail, Inc.盘中异动 快速下挫5.14%报12.56美元
Grail, Inc.盘中异动 股价大跌5.02%报13.25美元
市场透视 · 09-24
Grail, Inc.盘中异动 股价大跌5.02%报13.25美元
监管里程碑事件!法院判定欧盟委员会在Illumina(ILMN.US)-Grail(GRAL.US)收购案中越权
智通财经 · 09-03
监管里程碑事件!法院判定欧盟委员会在Illumina(ILMN.US)-Grail(GRAL.US)收购案中越权
更新版 1-Illumina赢得 "圣杯 "之战,打击欧盟兼并势力
Reuters · 09-03
更新版 1-Illumina赢得 "圣杯 "之战,打击欧盟兼并势力
欧盟最高法院支持 Illumina 对抗欧盟对 Grail 交易的调查
Reuters · 09-03
欧盟最高法院支持 Illumina 对抗欧盟对 Grail 交易的调查
更新版 1-癌症测试制造商 Grail 裁员 350 人,作为重组计划的一部分
Reuters · 08-14
更新版 1-癌症测试制造商 Grail 裁员 350 人,作为重组计划的一部分
Grail 将裁员,2024 年计划招聘人数减少约 30
Reuters · 08-14
Grail 将裁员,2024 年计划招聘人数减少约 30
受生物技术资金紧缩影响,Illumina 预计核心业务全年销售额将下降
Reuters · 08-07
受生物技术资金紧缩影响,Illumina 预计核心业务全年销售额将下降
分析-没有安全的大宗交易,投资银行家采取行动保障费用
Reuters · 07-22
分析-没有安全的大宗交易,投资银行家采取行动保障费用
BUZZ-纳斯达克生物技术指数创逾两年半新高
Reuters · 07-17
BUZZ-纳斯达克生物技术指数创逾两年半新高
更新版 1-Illumina 将在第二季度计提 14.7 亿美元与 Grail 相关的商誉减值费用
Reuters · 06-28
更新版 1-Illumina 将在第二季度计提 14.7 亿美元与 Grail 相关的商誉减值费用
Illumina 将在第二季度计提与 Grail 相关的 14.7 亿美元减值费用
Reuters · 06-28
Illumina 将在第二季度计提与 Grail 相关的 14.7 亿美元减值费用
80亿美元估值黄粱梦一场,拖垮因美纳后Grail(GRAL.US)还能撑多久?
智通财经 · 06-27
80亿美元估值黄粱梦一场,拖垮因美纳后Grail(GRAL.US)还能撑多久?
BUZZ--美国股票走势-Credo Technology、礼来公司、Gogoro
Reuters · 06-26
BUZZ--美国股票走势-Credo Technology、礼来公司、Gogoro
BUZZ--美国股票走势-Credo Technology、礼来公司、Gogoro
Reuters · 06-26
BUZZ--美国股票走势-Credo Technology、礼来公司、Gogoro
公司概况
公司名称:
GRAIL, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Grail, Inc.于2015年9月11日在特拉华州注册成立。该公司是一家医疗保健公司,致力于通过开创癌症早期检测的新技术来拯救生命和改善健康。该公司建立了一个由科学家、工程师和医生组成的多学科组织,它正利用下一代测序(NGS)、人群规模临床研究以及最先进的计算机科学和数据科学的力量来克服医学的最大挑战之一。该公司利用该公司的平台技术,开发了一种多癌症早期检测血液检测方法,在临床研究中证明了从一次抽血中就可以检测出50多种癌症类型,并能高度准确地定位癌症信号。
发行价格:
--
{"stockData":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":13.38,"timestamp":1727886035699,"preClose":13.25,"halted":0,"volume":160085,"delay":0,"floatShares":31049100,"shares":31049148,"eps":-92.86532,"marketStatus":"交易中","marketStatusCode":2,"change":0.13,"latestTime":"10-02 12:20:51 EDT","open":13.25,"high":13.71,"low":13.17,"amount":2152914.32845,"amplitude":0.040755,"askPrice":13.39,"askSize":618,"bidPrice":13.37,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-92.86532,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1727899200000},"adr":0,"adjPreClose":13.25,"preHourTrading":{"tag":"盘前","latestPrice":13.23,"preClose":13.25,"latestTime":"09:29 EDT","volume":512,"amount":6784.32,"timestamp":1727875799999},"postHourTrading":{"tag":"盘后","latestPrice":13.25,"preClose":13.25,"latestTime":"19:12 EDT","volume":5376,"amount":71234.91,"timestamp":1727824338786},"volumeRatio":0.445432,"impliedVol":0.8091,"impliedVolPercentile":0.3676},"requestUrl":"/m/hq/s/GRAL/wiki","defaultTab":"wiki","newsList":[{"id":"2472337056","title":"Grail, Inc.盘中异动 快速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472337056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472337056?lang=zh_cn&edition=full","pubTime":"2024-10-01 02:23","pubTimestamp":1727720633,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日02时23分,Grail, Inc.股票出现异动,股价急速下跌5.21%。Grail, Inc.股票所在的生命科学行业中,整体跌幅为0.14%。其相关个股中,Bioaffinity Technologies Inc C/Wts 07/09/2027 、23Andme Holding Co.、Inotiv, Inc.涨幅较大,Applied Dna Sciences, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃,换手率分别为39.43%、11.72%、6.03%,振幅较大的相关个股有Applied Dna Sciences, Inc.、23Andme Holding Co.、Neuronetics, Inc.,振幅分别为33.18%、21.52%、16.49%。Grail, Inc.公司简介:GRAIL Inc是一家医疗保健公司,致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100102235398e39e70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100102235398e39e70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2470708012","title":"Grail, Inc.盘中异动 快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470708012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470708012?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:59","pubTimestamp":1727449159,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时59分,Grail, Inc.股票出现波动,股价大幅上涨5.00%。截至发稿,该股报14.28美元/股,成交量16.8538万股,换手率0.54%,振幅5.00%。Grail, Inc.股票所在的生命科学行业中,整体涨幅为0.49%。Grail, Inc.公司简介:GRAIL Inc是一家医疗保健公司,致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272259199719d264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272259199719d264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2470502260","title":"Grail, Inc.盘中异动 快速下挫5.14%报12.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470502260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470502260?lang=zh_cn&edition=full","pubTime":"2024-09-26 00:08","pubTimestamp":1727280498,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日00时08分,Grail, Inc.股票出现异动,股价快速下跌5.14%。截至发稿,该股报12.56美元/股,成交量40.9909万股,换手率1.32%,振幅6.72%。Grail, Inc.股票所在的生命科学行业中,整体跌幅为1.27%。Grail, Inc.公司简介:GRAIL Inc是一家医疗保健公司,致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926000818a1dc7e6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926000818a1dc7e6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2469210911","title":"Grail, Inc.盘中异动 股价大跌5.02%报13.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469210911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469210911?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:24","pubTimestamp":1727119467,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时24分,Grail, Inc.股票出现异动,股价快速下跌5.02%。截至发稿,该股报13.25美元/股,成交量56.774万股,换手率1.83%,振幅6.02%。Grail, Inc.股票所在的生命科学行业中,整体跌幅为0.08%。Grail, Inc.公司简介:GRAIL Inc是一家医疗保健公司,致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924032427ab65652b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924032427ab65652b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139","BNR"],"gpt_icon":0},{"id":"2464277008","title":"监管里程碑事件!法院判定欧盟委员会在Illumina(ILMN.US)-Grail(GRAL.US)收购案中越权","url":"https://stock-news.laohu8.com/highlight/detail?id=2464277008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464277008?lang=zh_cn&edition=full","pubTime":"2024-09-03 17:25","pubTimestamp":1725355517,"startTime":"0","endTime":"0","summary":"智通财经获悉,根据欧盟最高法院的一项裁决,基因测序公司Illumina放弃以70亿美元收购癌症检测供应商Grail的交易本不应受到欧盟的调查。欧盟委员会此前对Illumina以70亿美元收购Grail的罚款裁决,标志着欧盟委员会首次使用新的权力来监管对收入很少或没有收入的初创企业的收购,这些初创企业此前逃过了反垄断监管。在周二的裁决之后,Illumina针对欧盟委员会裁决提出的其他几项上诉现在可能会被驳回。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4534","BK4585","ILMN","BK4535","BK4588","BK4139","GRAL","BK4121","BK4548"],"gpt_icon":0},{"id":"2464217528","title":"更新版 1-Illumina赢得 \"圣杯 \"之战,打击欧盟兼并势力","url":"https://stock-news.laohu8.com/highlight/detail?id=2464217528","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464217528?lang=zh_cn&edition=full","pubTime":"2024-09-03 16:41","pubTimestamp":1725352890,"startTime":"0","endTime":"0","summary":"不过,这对Illumina公司的影响可能有限,该公司在6月份再次分拆了Grail公司,以遵守欧盟的命令,保留了14.5%的少数股权。2022 年,在 Illumina 对欧盟的兼并审查提出质疑后,欧盟普通法院裁定欧盟执委会胜诉。Illumina表示,欧盟法院的裁决意味着它不必支付罚款。\"今天的判决证实了Illumina长期以来的观点,即欧盟执委会对这一并购案的管辖权是越权的。这些案件是 C-611/22 P Illumina 诉欧盟执委会案和 C-625/22 P Grail 诉欧盟执委会案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4585","BK4548","GRAL","BK4121","BK4588","BK4535","BK4139","ILMN"],"gpt_icon":0},{"id":"2464825698","title":"欧盟最高法院支持 Illumina 对抗欧盟对 Grail 交易的调查","url":"https://stock-news.laohu8.com/highlight/detail?id=2464825698","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464825698?lang=zh_cn&edition=full","pubTime":"2024-09-03 15:48","pubTimestamp":1725349724,"startTime":"0","endTime":"0","summary":" 路透布鲁塞尔9月3日 - 欧洲最高法院周二支持美国基因测序公司Illumina 对抗欧盟反垄断监管机构对其71亿美元收购癌症诊断测试制造商Grail 的调查。普通法院在 2022 年做出了有利于欧盟执委会的裁决。这两起案件分别是 C-611/22 P Illumina 诉欧盟执委会案和 C-625/22 P Grail 诉欧盟执委会案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4534","ILMN","BK4588","BK4121","BK4585","BK4548","GRAL","BK4139"],"gpt_icon":0},{"id":"2459370601","title":"更新版 1-癌症测试制造商 Grail 裁员 350 人,作为重组计划的一部分","url":"https://stock-news.laohu8.com/highlight/detail?id=2459370601","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459370601?lang=zh_cn&edition=full","pubTime":"2024-08-14 04:44","pubTimestamp":1723581893,"startTime":"0","endTime":"0","summary":" 路透8月13日 - Grail Inc 周二表示,随着这家诊断公司专注于开发其旗舰产品Galleri癌症检测试剂盒,它已裁减了约350个现有职位。该公司于今年6月从基因测序机制造商Illumina的 ,并在纳斯达克上市,它正通过Galleri与医疗系统、雇主和人寿保险公司建立 商业合作关系。\"Grail在一份声明中说:\"作为此次重组的一部分,我们将把现有员工人数和2024年的计划招聘人数减少约30%,并大幅减少对Galleri以外产品项目的投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2459134292","title":"Grail 将裁员,2024 年计划招聘人数减少约 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2459134292","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459134292?lang=zh_cn&edition=full","pubTime":"2024-08-14 04:11","pubTimestamp":1723579885,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透8月13日 - 癌症测试制造商Grail 周二表示,作为重组计划的一部分,该公司将把现有员工人数和2024年计划招聘的员工人数减少约30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2457889833","title":"受生物技术资金紧缩影响,Illumina 预计核心业务全年销售额将下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2457889833","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457889833?lang=zh_cn&edition=full","pubTime":"2024-08-07 06:51","pubTimestamp":1722984679,"startTime":"0","endTime":"0","summary":" 路透8月6日 - 基因测序机器制造商 Illumina 周二预测,2024年其核心业务的销售额将下降,这表明对基因测试所用仪器的低迷需求可能会延续到今年。该公司预计,Illumina 核心业务收入将比上年下降 2% 至 3%。在Illumina的两个报告分部,即Core Illumina和Grail 中,后者已于6月24日分拆。总部位于加州圣迭戈的Illumina公司第二季度的季度营收为11.1亿美元,而分析师预计为10.8亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4534","ILMN","BK4588","BK4121","BK4585","BK4548","GRAL","BK4139"],"gpt_icon":0},{"id":"2453752263","title":"分析-没有安全的大宗交易,投资银行家采取行动保障费用","url":"https://stock-news.laohu8.com/highlight/detail?id=2453752263","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453752263?lang=zh_cn&edition=full","pubTime":"2024-07-22 18:00","pubTimestamp":1721642426,"startTime":"0","endTime":"0","summary":"在欧洲,欧盟执委会在 2022 年和 2023 年分别发布了两项和一项禁止交易的决定,而 2021 年和 2020 年则没有。据接受采访的交易商称,包括高盛 、摩根大通 和摩根士丹利 在内的顶级投行正在争取在某些交易中获得高达25%的分手费,具体取决于交易的规模。摩根大通拒绝就此置评,高盛也没有回应置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","IRBT","LU1935043023.USD","LU1861217088.USD","IE00BKVL7J92.USD","LU1935043536.SGD","IE00B7SZLL34.SGD","LU0868494708.USD","DFS","LU0310800965.SGD","LU0942090050.USD","LU1668664300.SGD","BK4106","LU1201861249.SGD","LU0109392836.USD","LU1803068979.SGD","GRAL","FIS","IE00BFXG1179.USD","LU0971096721.USD","IE0034235188.USD","BK4504","SAVE","LU0980610538.SGD","LU2237443549.SGD","LU1066053197.SGD","LU1496350502.SGD","LU0006061336.USD","CI","LU1074936037.SGD","LU2237443978.SGD","X","HA","LU1059921491.USD","LU1506573853.SGD","LU2326559502.SGD","ORCL","LU2237443622.USD","LU0157215616.USD","LU1496350171.SGD","LU1861220207.SGD","LU0314104364.USD","LU2237443382.USD","LU2360107671.USD","LU0175139822.USD","LU1935042991.SGD","CVX","JBLU","BK4166","LU1069347547.HKD"],"gpt_icon":0},{"id":"2452945966","title":"BUZZ-纳斯达克生物技术指数创逾两年半新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2452945966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452945966?lang=zh_cn&edition=full","pubTime":"2024-07-17 02:02","pubTimestamp":1721152922,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 7月16日 - ** 纳斯达克生物技术指数下午交易中上涨 1.3%,报 4.885.99 点 ** 指数创逾两年半新高 ** 早期生物技术公司 (link) 在很大程度上依赖风险投资和上市作为融资选择;今年对生物技术公司的 IPO 投资显示出进一步复苏的迹象** 涨幅最大的公司包括太平洋生物科学公司 、Caribou生物科学公司 和Grail公司 。 ** 截至 7 月 12 日的一周内,该指数上涨了 6.8** 年初至今,该指数上涨了 11.8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4121","CRBU","GRAL","BK4539","PACB","BK4588","BK4585","BK4139","NBI"],"gpt_icon":0},{"id":"2446859309","title":"更新版 1-Illumina 将在第二季度计提 14.7 亿美元与 Grail 相关的商誉减值费用","url":"https://stock-news.laohu8.com/highlight/detail?id=2446859309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446859309?lang=zh_cn&edition=full","pubTime":"2024-06-28 05:13","pubTimestamp":1719522811,"startTime":"0","endTime":"0","summary":" 路透6月27日 - Illumina 周四表示,该公司将在第二季度计提 14.7 亿美元的商誉减值费用,这笔费用与最近分拆的 Grail Inc 有关。作为一家独立公司,Grail寄希望于与医疗系统、雇主和人寿保险公司建立商业合作关系,通过其旗舰产品癌症检测测试推动公司的近期增长。周二上市后, Grail 的 股价下跌了近 14%。本周四,Illumina 公司表示,可能会在第二季度为 Grail 的在研无形资产追加约 4.2 亿美元的减值支出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4585","BK4548","GRAL","BK4121","BK4588","BK4535","ILMN"],"gpt_icon":0},{"id":"2446057598","title":"Illumina 将在第二季度计提与 Grail 相关的 14.7 亿美元减值费用","url":"https://stock-news.laohu8.com/highlight/detail?id=2446057598","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446057598?lang=zh_cn&edition=full","pubTime":"2024-06-28 04:49","pubTimestamp":1719521380,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透6月27日 - Illumina 周四表示,该公司将在第二季度计提14.7亿美元的商誉减值费用,这笔费用与最近分拆的Grail Inc 有关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4535","BK4534","BK4588","ILMN","GRAL","BK4548","BK4121"],"gpt_icon":0},{"id":"2446373086","title":"80亿美元估值黄粱梦一场,拖垮因美纳后Grail(GRAL.US)还能撑多久?","url":"https://stock-news.laohu8.com/highlight/detail?id=2446373086","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446373086?lang=zh_cn&edition=full","pubTime":"2024-06-27 11:00","pubTimestamp":1719457255,"startTime":"0","endTime":"0","summary":"2020年9月9日,Grail申请在纳斯达克挂牌上市。手握天胡剧本,Grail的多癌早检业务迅速起飞。样本需求量大、随访时间长,势必导致Grail需要承担巨额的研发费用。截至今年一季度,Grail已售出超过18万个商业测试,进行了涉及38.5万人的临床试验。经过3年拉扯,Illumina最终败诉,并于去年12月17日宣布剥离Grail。80亿美元估值缩水背后相比于2021年首次IPO前的80亿美元估值,如今的Grail显然“大势已去”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GRAL"],"gpt_icon":0},{"id":"2446822499","title":"BUZZ--美国股票走势-Credo Technology、礼来公司、Gogoro","url":"https://stock-news.laohu8.com/highlight/detail?id=2446822499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446822499?lang=zh_cn&edition=full","pubTime":"2024-06-26 01:49","pubTimestamp":1719337748,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月25日 - 周二,受Nvidia和其他超级大盘股走强的提振,科技股重仓股纳斯达克指数大涨逾1%,而道琼斯指数则因投资者等待本周公布的重要通胀数据以进一步了解美国货币政策路径而下滑。美东时间13:33,道琼斯工业平均指数 下跌0.75%,报39,116.52点。标普500指数 上涨0.17%,报5457.27点;纳斯达克综合指数 上涨0.92%,报17658.657点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTBT","MNQmain","WVE","WMT","CORZ","GGR","LESL","CRDO","SPR","SE","BUZZ","GRAL","DXD","CCL","CPRI","LLY","TQQQ","POOL","QLD","SDOW",".DJI","GE","QID","ALB","HUT","SEDG","ALTM","DJX","SQQQ","GPS","COIN","DD","MQ","NVDA","DOG","DDM","OMI","BIRK","FDX","MARA","QQQ","UBER",".IXIC","TEM","NQmain","NSC","RIOT","IE00B3M56506.USD","UDOW","PSQ"],"gpt_icon":0},{"id":"2446224918","title":"BUZZ--美国股票走势-Credo Technology、礼来公司、Gogoro","url":"https://stock-news.laohu8.com/highlight/detail?id=2446224918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446224918?lang=zh_cn&edition=full","pubTime":"2024-06-26 01:49","pubTimestamp":1719337748,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月25日 - 周二,受Nvidia和其他超级大盘股走强的提振,科技股重仓股纳斯达克指数大涨逾1%,而道琼斯指数则因投资者等待本周公布的重要通胀数据以进一步了解美国货币政策路径而下滑。美东时间13:33,道琼斯工业平均指数 下跌0.75%,报39,116.52点。标普500指数 上涨0.17%,报5457.27点;纳斯达克综合指数 上涨0.92%,报17658.657点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MQ","SQQQ","BIRK","CPRI","BUZZ","POOL","MARA","PSQ","ALB","CRDO","WMT","WVE","SEDG","HUT",".IXIC","TEM","GGR","DOG","NSC","OMI","SDOW","COIN","FDX","CCL","MNQmain","DJX","GE","UDOW",".DJI","SE","RIOT","ALTM","DXD","QLD","GRAL","LESL","LLY","NVDA","DD","GPS","UBER","CORZ","TQQQ","BTBT","QQQ","SPR","IE00B3M56506.USD","DDM","QID","NQmain"],"gpt_icon":0}],"profile":{"websiteUrl":"http://grail.com","stockEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0609},{"period":"3month","weight":-0.1446},{"period":"6month","weight":-0.0502},{"period":"ytd","weight":-0.0502}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0311},{"period":"6month","weight":0.1083},{"period":"1year","weight":0.3307},{"period":"ytd","weight":0.1963}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Grail, Inc.于2015年9月11日在特拉华州注册成立。该公司是一家医疗保健公司,致力于通过开创癌症早期检测的新技术来拯救生命和改善健康。该公司建立了一个由科学家、工程师和医生组成的多学科组织,它正利用下一代测序(NGS)、人群规模临床研究以及最先进的计算机科学和数据科学的力量来克服医学的最大挑战之一。该公司利用该公司的平台技术,开发了一种多癌症早期检测血液检测方法,在临床研究中证明了从一次抽血中就可以检测出50多种癌症类型,并能高度准确地定位癌症信号。","exchange":"NASDAQ","name":"GRAIL, Inc.","nameEN":"GRAIL, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRAIL, Inc.,GRAL,GRAIL, Inc.股票,GRAIL, Inc.股票老虎,GRAIL, Inc.股票老虎国际,GRAIL, Inc.行情,GRAIL, Inc.股票行情,GRAIL, Inc.股价,GRAIL, Inc.股市,GRAIL, Inc.股票价格,GRAIL, Inc.股票交易,GRAIL, Inc.股票购买,GRAIL, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}